| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/06/2010 | US7691635 Such as heat resistant diazomethyl compounds; kits for solid phase nucleic acid synthesis |
| 04/06/2010 | US7691632 Kit for detecting the level of cyclin-dependent kinase inhibitor P16 gene expression |
| 04/06/2010 | US7691628 For drug screening for substances useful in treatment of lipid metabolism dysfunctions associated with apolipoprotein C-III; atherosclerosis, hyperlipidaemia, diabetes, obesity, syndrome X, or resistance to insulin and cardiac and coronary diseases |
| 04/06/2010 | US7691623 Method for the fabrication of a “lab on chip” from photoresist material for medical diagnostic applications |
| 04/06/2010 | US7691606 Soluble GDNFR (Glial-cell Derived Neurotrophic Factor) that retains both ligand binding, and receptor signaling function (via Ret receptor tyrosine kinase) used to impart, restore, or enhance GDNFR alpha -ligand (preferably GDNF) responsiveness to cells; kidney diseases |
| 04/06/2010 | US7691595 Sensitive immunochromatographic assay |
| 04/06/2010 | US7691594 Anticancer agent |
| 04/06/2010 | US7691593 Regulation of lung tissue by patched therapeutics and formulations and uses related thereto |
| 04/06/2010 | US7691592 Using receptor tyrosine phosphatases as tools in identifying modulators for prevention and treatment of nervous system, cell proliferative and respiratory system disorders |
| 04/06/2010 | US7691591 Methods of identifying and isolating cells expressing DC-sign |
| 04/06/2010 | US7691590 Reducing myelin-mediated inhibition of axon regeneration |
| 04/06/2010 | US7691589 Effective as an anti-differentiator while the chicken differentiable cell is being cultured; enables stable supply of the LIF protein derived from chickens |
| 04/06/2010 | US7691588 Ligand having agonistic activity to mutated receptor |
| 04/06/2010 | US7691587 Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptides |
| 04/06/2010 | US7691586 Method for predicting and judging the recurrence of liver cancer after treating liver cancer |
| 04/06/2010 | US7691585 Human Zven polypeptides |
| 04/06/2010 | US7691584 Screening of compounds for OCT3 transporter activity |
| 04/06/2010 | US7691583 High sensitivity mechanical resonant sensor |
| 04/06/2010 | US7691582 Methods of secretory vimentin detection and modulation |
| 04/06/2010 | US7691581 Means and methods for diagnosing a treponema infection |
| 04/06/2010 | US7691580 Reverse protein delivery into cells on coded microparticles |
| 04/06/2010 | US7691578 Methods and compositions for treating obesity |
| 04/06/2010 | US7691569 detecting the expression level of a nucleic acid depending upon the rate of hematopoiesis or the distribution of hematopoietic cells along their maturation pathway in patient |
| 04/06/2010 | US7691567 Fortilin binds p53 and prevents apoptosis; fortilin inhibitor select from the group, polypeptide, an antibody, monoclonal antibody, nucleic acid molecule, antisense molecule or a ribozyme |
| 04/06/2010 | US7691566 Compositions and methods for treatment of cancer |
| 04/06/2010 | US7691564 detecting G protein coupled receptor signaling in the presence of a test sample using fluorescence resonance energy transfer (FRET); for drug screening and G-protein couple receptors (GPCRs) de-orphaning |
| 04/06/2010 | US7691563 Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds |
| 04/06/2010 | US7691414 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports |
| 04/06/2010 | US7691395 BASB119 polypeptide and polynucleotide from Moraxella catarrhalis |
| 04/06/2010 | US7691390 polypeptide and isolated nucleic acid encoding the polypeptide for SARS CoV protein 3a, which can serve as a target for elucidating the mechanisms of SARS and developing vaccines and therapeutics |
| 04/06/2010 | US7691385 Polypeptides encoded by polynucleotides that are useful for detecting resistance to streptogramin A or to streptogramin B and related compounds |
| 04/06/2010 | US7691384 using a human Fc epsilon receptor (Fc68 R) to detect epsilon immunoglobulin (IgE); detecting a plant allergy in a canid, felid or equid |
| 04/06/2010 | US7691376 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes |
| 04/06/2010 | US7691328 Chip using method and test chip |
| 04/06/2010 | US7691255 Sensor, measuring device, and measuring method |
| 04/06/2010 | US7690328 Milk conveyer device |
| 04/06/2010 | US7690246 System and method for dynamic lubrication adjustment for a lubrication analysis system |
| 04/06/2010 | CA2462506C Compositions, methods and kits pertaining to luminescent compounds |
| 04/06/2010 | CA2455404C Urine test device |
| 04/06/2010 | CA2445035C Mutants of green fluorescent protein |
| 04/06/2010 | CA2381954C Method for detecting nucleic acid target sequences involving in vitro transcription from an rna polymerase promoter |
| 04/06/2010 | CA2350404C Detection of prostatitis |
| 04/06/2010 | CA2321070C Method and apparatus for synthesis of arrays of dna probes |
| 04/06/2010 | CA2280930C Protein markers for lung cancer and use thereof |
| 04/06/2010 | CA2271952C Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders |
| 04/06/2010 | CA2252466C Hepatitis b monoclonal antibodies |
| 04/04/2010 | CA2681452A1 Measuring device for monitoring the corrosion of a steel reinforcement |
| 04/03/2010 | CA2640415A1 Methods for predicting and detecting intolerance to an hypolipidemic agent |
| 04/02/2010 | CA2681436A1 Blood coagulation assays |
| 04/02/2010 | CA2640501A1 Fabrication and use of submicron wide suspended structures |
| 04/01/2010 | WO2010037134A2 Multi-stage stem cell carcinogenesis |
| 04/01/2010 | WO2010037083A1 Screen for anti-viral compounds against hepatitis b virus |
| 04/01/2010 | WO2010037042A2 Methods for detecting and treating cancer |
| 04/01/2010 | WO2010037041A2 Frizzled-binding agents and uses thereof |
| 04/01/2010 | WO2010037027A2 Immunization of avians by mucosal administration of non-replicating vectored vaccines |
| 04/01/2010 | WO2010037001A2 Selective oxidation of 5-methylcytosine by tet-family proteins |
| 04/01/2010 | WO2010036930A1 Methods and kits for detecting joint infection |
| 04/01/2010 | WO2010036924A2 Inflammatory genes and microrna-21 as biomarkers for colon cancer prognosis |
| 04/01/2010 | WO2010036922A1 Profiling reactive oxygen, nitrogen and halogen species |
| 04/01/2010 | WO2010036918A2 Intracellular dna receptor |
| 04/01/2010 | WO2010036913A2 Quantifying cell migration in wound healing assays |
| 04/01/2010 | WO2010036912A2 Capturing particles |
| 04/01/2010 | WO2010036909A1 Spectroscopic imaging microscopy |
| 04/01/2010 | WO2010036901A1 Methods and kits for diagnosing obstructive sleep apnea |
| 04/01/2010 | WO2010036837A1 Coordination of a technetium imaging complex on a bioactive apoptosis targeting agent |
| 04/01/2010 | WO2010036827A1 Method for detecting analytes |
| 04/01/2010 | WO2010036795A2 Screening methods for identifying specific staphylococcus aureus inhibitors |
| 04/01/2010 | WO2010036794A1 Methods for identifying modulators of the pp2a b56 beta regulatory subunit |
| 04/01/2010 | WO2010036706A1 Recombination sequence (rs) rearrangement frequency as a measure of central b cell tolerance |
| 04/01/2010 | WO2010036667A2 Apparatus and method for separation of particles suspended in a liquid from the liquid in which they are suspended |
| 04/01/2010 | WO2010036470A1 Method for detection of antigen-specific antibodies in biological samples |
| 04/01/2010 | WO2010036342A2 Urinary biomarkers for predicting long-term dialysis |
| 04/01/2010 | WO2010036339A2 A method of detecting antibodies and antibody-hiv virion complexes |
| 04/01/2010 | WO2010036322A1 Methods for identifying stem cells by detecting fluorescence of cells and syncytia |
| 04/01/2010 | WO2010036287A1 Intermittent detection during analytical reactions |
| 04/01/2010 | WO2010036206A1 Method and apparatus for the quantitative determination of total lactones in andrographis paniculata |
| 04/01/2010 | WO2010036195A1 A method of creating a biosensor based on gold nanoparticles assembled on monolayers of a dithiol in which the method involves reacting the dithiol monolayer with dithiothreitol |
| 04/01/2010 | WO2010036134A1 Elisa assay for detecting antibodies against blv surface antigen gp 51 in bovine serum |
| 04/01/2010 | WO2010036038A2 Quantification method of functional groups of organic layer |
| 04/01/2010 | WO2010035889A1 Agent that modulates physiological condition of pests, involved in insect voltage-gated potassium channel activity |
| 04/01/2010 | WO2010035888A1 Biomarker for microdomain disorder |
| 04/01/2010 | WO2010035811A1 Blood sugar information processor, blood sugar information processing method, and blood sugar information processing program |
| 04/01/2010 | WO2010035530A1 Measurement result display method and analysis device |
| 04/01/2010 | WO2010035504A1 Peptide for use in simultaneous protein quantification of metabolizing enzymes using mass spectrometric analysis apparatus |
| 04/01/2010 | WO2010035465A1 Anti-tuna vasa antibody |
| 04/01/2010 | WO2010035272A1 System and methods for diagnosing cancer |
| 04/01/2010 | WO2010035259A2 Compositions and methods for diagnosing and treating b-cll |
| 04/01/2010 | WO2010035204A1 Detection system and method |
| 04/01/2010 | WO2010035174A1 Magnetic-label sensor and cartridge |
| 04/01/2010 | WO2010035129A2 Method for separating the constituents of a complex mixture of proteins to submit to proteomic analysis and apparatus therefor |
| 04/01/2010 | WO2010035075A1 Individual 5-fluorouracile dose optimization in folfox treatment |
| 04/01/2010 | WO2010035049A1 Microtumours |
| 04/01/2010 | WO2010034982A1 Ligands for aggregated tau molecules |
| 04/01/2010 | WO2010034960A1 Non-human animals having psychiatric disorders, method for obtaining same, and use thereof for drug screening |
| 04/01/2010 | WO2010034956A1 Novel method for non-radioactively measuring protein synthesis and protein marking in living cells |
| 04/01/2010 | WO2010034870A1 Use of a protein sequence of localisation and endolysosomal degradation |
| 04/01/2010 | WO2010034846A1 Rapid procedure for detection of microorganisms with magnetic particles |
| 04/01/2010 | WO2010034825A2 Novel antibodies recognizing native annexin a3 |
| 04/01/2010 | WO2010034801A1 Methods for determining sodium-proton-exchanger ligand efficiency |
| 04/01/2010 | WO2010034752A1 Bioluminescent fungi and their application in the study of fungal infections |